Business

Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

REDWOOD CITY, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its full year and fourth quarter 2025 financial results will be released after market close on Monday, March 9, 2026. Starting at 4:30 p.m. Eastern Time on March 9, 2026, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. A webcast replay will be available on https://investors.coherus.com following t

articleCoherus Oncology, Inc.March 2, 20262/company/coherus-biosciences-inc/news/coherus-oncology-to-report-full-year-and-fourth-quarter-2025-financial-results-on-march-9-2026
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

About this update from Coherus Oncology, Inc.

[{"type":"image","alt":"Coherus Oncology, Inc.","displaySize":"","headline":null,"caption":"Coherus Oncology, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":90,"url":"https://media.zenfs.com/en/globenewswire.com/de46623a0f67971b50edcbf1ccfac170"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Oe14ACN4sd6wayCRQj8VlQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyNjtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/de46623a0f67971b50edcbf1ccfac170","width":300,"height":90}},"lazy":false},{"type":"text","content":"REDWOOD CITY, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS), today announced that its full year and fourth quarter 2025 financial results will be released after market close on Monday, March 9, 2026. Starting at 4:30 p.m. Eastern Time on March 9, 2026, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update.","length":420,"tagName":"p"},{"type":"text","content":"A webcast replay will be available on https://investors.coherus.com following the conclusion of the live conference call.","length":121,"tagName":"p"},{"type":"text","content":"Conference Call Information","length":27,"tagName":"p"},{"type":"text","content":"When: Monday, March 9, 2026, starting at 4:30 p.m. Eastern Standard Time","length":72,"tagName":"p"},{"type":"text","content":"To access the conference call, please pre-register through the following link to receive dial-in information and a personal PIN to access the live call: https://register-conf.media-server.com/register/BI343f960d41224739b123cc4c86fdce7a","length":235,"tagName":"p"},{"type":"text","content":"Webcast: https://edge.media-server.com/mmc/p/2otjwz7w","length":53,"tagName":"p"},{"type":"text","content":"The press release with the full year and fourth quarter 2025 financial results and related materials will be available at https://investors.coherus.com before the start of the conference call.","length":192,"tagName":"p"},{"type":"text","content":"A live and archived webcast will be available on the “Investors” section of the Coherus website at https://investors.coherus.com/events-presentations.","length":150,"tagName":"p"},{"type":"text","content":"Please dial in 15 minutes early to ensure a timely connection to the call.","length":74,"tagName":"p"},{"type":"text","co...

More updates from Coherus Oncology, Inc.

financial resultsOncology